RSS Feeds
Search

Press releases

Stay current with the latest press releases from within the industry.

HFA MDI developments at CCL Pharmaceuticals

Release issued 10th January 2000

HFA MDI Development Projects

CCL's contract R&D Laboratory has recently finished the development of several metered dose respiratory inhalers products (mdis). The projects, which were delivered on time, were for two major European pharmaceutical companies who wanted to transfer their existing respiratory franchise from CFC to HFA technologies.

For one client, CCL carried out a full development program covering formulation, analytical method development, validation, stability batch manufacture and stability testing. For another client, CCL utilised the clients' formulation to carry out all of the remaining development stages. CCL was able to source the correct combination of actuator and valve systems from well-known world-class device suppliers.

Both clients chose CCL because of CCL's independent position as a contract development and manufacturing house, and CCL's ability to manufacture the product for commercial supply in their new facility after regulatory approval had been gained.

For further information on CCL Pharmaceutical's development and manufacturing abilities please see the Company Profile or contact:

Clive Albany (Managing Director) (mailto:clive.albany@ccl-industries.co.uk)

Company details

If you want to find out more about the company visit Miza Pharmaceuticals (UK) Ltd profile.

Latest Miza Pharmaceuticals (UK) Ltd press releases

Related reports

Market Research Reports provided by reports.iptechex.com

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us